A Study for Patients With Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT00520923

Femme et Homme

Extrait

The purpose of this study is to test the hypothesis that 1 or more dose levels of LY2140023 given orally to patients with schizophrenia twice daily for 4 weeks will have significantly greater effect than placebo.


Critère d'inclusion

  • Schizophrenia


Liens